)
)
Ziccum Investor Relations Material
Latest events
Status Update
Ziccum
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Ziccum
Access all reports
Ziccum is a Sweden-based pharmaceutical company specializing in the development of vaccines. It focuses on creating new thermostable versions of vaccines and biologics through its patented drying technology, LaminarPace. This unique method relies on mass transfer instead of heat transfer, enabling the production of particle-engineered, thermostable dry powder biopharmaceuticals. These powders can be easily handled and transported, and they are suitable for novel administration routes, eliminating the need for cold chain logistics. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ZICC
Country
🇸🇪 Sweden